Psoriatic Dermal-Derived Mesenchymal Stem Cells Induced C3 Expression in Keratinocytes
DOI: https://doi.org/10.2147/CCID.S363737
2022-08-03
Abstract:Aihong Peng, 1 Funa Lu, 1 Jianxiao Xing, 1 Yu Dou, 1 Yuanjun Yao, 1 Juan Li, 1 Junqin Li, 1 Ruixia Hou, 1 Kaiming Zhang, 2 Guohua Yin 1 1 Shanxi Key Laboratory of Stem Cells for Immunological Dermatosis, Institute of Dermatology, Taiyuan Central Hospital of Shanxi Medical University, Taiyuan, People's Republic of China; 2 Shanxi Key Laboratory of Stem Cells for Immunological Dermatosis, Institute of Dermatology, Taiyuan Central Hospital, Taiyuan, People's Republic of China Correspondence: Guohua Yin, Shanxi Key Laboratory of Stem Cells for Immunological Dermatosis, Institute of Dermatology, Taiyuan Central Hospital of Shanxi Medical University, No. 5, Dong San Dao Xiang, Jiefang Road, Taiyuan, People's Republic of China, Tel +86-0351-5656080, Email Purpose: Our recent studies found a splice region mutation in C3 accompanied by a significantly increased C3 in psoriatic peripheral blood. Mesenchymal stem cells (MSCs) are a key immunological suppression cell. We further investigate the regulation of MSCs on C3 in psoriasis. Patients and Methods: We analyzed the C3 and its upstream S100A9, S100A8 and downstream MCP1 in psoriatic and control skin, and in normal human epidermal keratinocytes (NHEKs) co-cultured with psoriatic versus control dermal-derived mesenchymal stem cells (DMSCs) by mRNA, iTRAQ (isobaric tags for relative and absolute quantitative) and simple Western analysis. Results: The mRNA and Simple Western analysis showed that the expression of C3, S100A8 and S100A9 are upregulated in psoriatic lesion (C3: mRNA, 9.23-fold, p = 0.0092; protein, 3.56-fold, p = 0.0244. S100A8: mRNA, 28.35-fold, p = 0.0015; protein, 4.68-fold, p = 0.0215. S100A9: mRNA, 79.45-fold, p = 0.0066; protein, 12.42-fold, p > 0.05). Moreover, the iTRAQ showed that C3 and S100A9 were significantly increased in NHEKs after co-cultured with psoriatic DMSCs compared to that of control DMSCs (C3: 3.40-fold, p = 0, FDR = 0; S100A9: 2.30-fold, p = 9.86E-241, FDR = 6.50E-239), verified by Simple Western. However, the expression of S100A8 and MCP1 was slightly different between the two groups. Conclusion: Our results suggest that psoriatic DMSCs contribute to the increased C3 expression in psoriatic lesion via upregulating S100A9, providing the theoretical basis for the role of C3 and DMSCs in the pathogenesis of psoriasis. Keywords: psoriasis, dermal mesenchymal stem cells, keratinocytes, C3, S100A9 Psoriasis is a common chronic recurrent inflammatory disease. 1 According to the World Health Organization's global report on psoriasis, it affects more than 2% of the world's population, 2 and its incidence rate has increased from 0.123% in 1984 to 0.47% in China. 3 Psoriasis is mainly caused by abnormal immune response induced by excessive proliferation of keratinocytes (KCs) and the migration of immature keratinocytes to the epidermis. 4,5 High recurrence rates seriously affect patients' quality of life, which is a huge challenge for global public health. Complement system is an inflammatory protein in the peripheral blood and tissue fluid. Complement C3, an important molecule in the complement pathway, plays an important role in both bypass and classical pathways. Studies showed that C3 protein is increased in serum, plasma, peripheral blood. Moreover, we found a splice region mutation of C3 and a significantly increased C3 protein in monozygotic twins discordant for psoriasis in our previous study. 6 The increased C3 expression may be originated from the local environment with high expression of TNF-α, IFN-γ and S100A8-S100A9. 7 Mesenchymal stem cells (MSCs) are a type of progenitor cells with the function of immune regulation widely existing in various tissues. MSCs play a role in promoting angiogenesis and vascular proliferation, 8–10 which are the most obvious pathological changes of psoriasis. Li et al found that human umbilical cord MSCs can inhibit C3a-C3aR signaling in chronic unpredictable mild stress model mice. 11 MSCs constitutively secrete factor H, a factor prohibiting the production of and inducing the degradation of C3. 12 Dermal mesenchymal stem cells (DMSCs) are a type of pluripotent stem cells isolated from skin tissue. DMSCs not only participate in the regeneration of skin tissue but also affect the skin microenvironment by secreting cytokines, growth factors and chemokines. Given that the external performance of psoriasis is skin, DMSCs have important implications for the pathophysiology of psoriasis. In the previous studies, DMSCs derived from psoriat -Abstract Truncated-